Month: October 2020
The scheduling modifications employers have made in response to COVID may have unintentional consequences for the employees’ group health plan eligibility for both the remainder of the current year.
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.
Even though the COVID-19 pandemic continues to roil the healthcare landscape financially, mergers and acquisitions remain robust thanks to heavy interest in the mental health and telehealth sectors, one expert says.
Amid fanfare in March, California officials celebrated the launch of a multimillion-dollar contract with Verily — Google’s health-focused sister company — that they said would vastly expand COVID testing among the state’s impoverished and underserved communities.
The survival of California’s dialysis clinics is in the hands of its voters this November. Sound familiar?
While COVID-19 infections spike uncontrollably across the country, California has turned the corner.
This Election Day, California voters are being asked to replenish funding for the state’s ambitious stem cell research program, with a well-financed campaign that’s making heady promises about curing diabetes, paralysis, cancer, and Parkinson’s and Alzheimer’s diseases.
The Trump administration has updated its reporting requirements for COVID-19 provider relief funds following pushback.
As COVID-19 took hold in March, U.S. doctors limited in-person appointments — and many patients avoided them — for fear of infection. The result was a huge increase in the volume of remote medical and behavioral health visits.
Most insurers on the Affordable Care Act’s (ACA's) insurance exchanges aren’t factoring COVID-19 into their 2021 rates or believe the pandemic will have a negligible effect, according to several experts.